There was no improvement in liver histology in patients with NASH fibrosis. Although treatment with Emricasan lowered serum ALT in the short‐term, it may have led to alternative mechanisms of cell death. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.